Press release
PARP Inhibitors Market to reach USD 11.56 Bn by 2029, emerging at a CAGR of 11.10 percent and forecast 2023-2029
PARP Inhibitors Market
Maximize Market Research Pvt Ltd, a leading global market research firm, has released an insightful report on the PARP Inhibitors Market. The report, titled "PARP Inhibitors Market: Unleashing Precision Medicine for Cancer Treatment," projects a market value of US$ 11.56 billion, showcasing a Compound Annual Growth Rate (CAGR) of 11.10% during the forecast period ending in 2029.
The report delves into the global landscape of Poly ADP-ribose Polymerases (PARP) inhibitors, exploring their emergence as a groundbreaking target in cancer therapy. With cancer ranking as the second leading cause of global mortality, the demand for effective drugs, targeted therapies, and precision medicines has surged. PARP inhibitors, exemplifying precision medicine, play a pivotal role by preventing damaged DNA repair in cancer cells, significantly impacting the proliferation of cancer cells. The report highlights the rising cases of cancer, government funding initiatives, and advancements in treatment techniques as key drivers elevating the PARP inhibitors market. It also acknowledges potential restraints posed by stringent government regulations.
The report employs a robust research methodology to provide a comprehensive analysis. Readers can request a free sample report to gain insights into the methodologies used for this in-depth research.
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/81566
PARP Inhibitors Market Dynamics:
The rising prevalence of cancer, government grants such as Cancer Australia's "Supporting People with Cancer" initiative, and effective partnerships among organizations are identified as major drivers propelling the market. On the flip side, strict government regulations are recognized as potential restraints.
PARP Inhibitors Market Regional Insights:
North America emerges as the frontrunner in the global PARP inhibitors market, driven by a growing geriatric population and a high incidence of diseases and disorders. The Asia-Pacific (APAC) region is projected to witness substantial growth due to increased research on BRCA-mutation tumors, ovarian cancer, and heightened disease awareness.
North America Emerges as Leading Force in Global PARP Inhibitors Market
The PARP inhibitors market sees North America at the forefront, wielding a dominant position globally. This supremacy is attributed to the region's growing geriatric population and the prevalence of numerous diseases and disorders. The rising number of elderly individuals is anticipated to be a major driver for the global PARP Inhibitors Market in the foreseeable future. The ongoing surge in research focused on BRCA-mutation tumors, ovarian cancer, and increased disease awareness augurs well for the market's revenue potential in the Asia-Pacific (APAC) region.
Comprehensive Analysis of the Global PARP Inhibitors Market
The primary objective of the report is to offer an exhaustive analysis of the Global PARP Inhibitors Market, encompassing all industry stakeholders. The report provides a detailed historical and current status of the industry, along with forecasted market size and trends. Utilizing a clear and straightforward language, the report simplifies the analysis of complex data. It covers all facets of the industry, featuring a dedicated study of key players, including market leaders, followers, and new entrants.
Request For Free Inquiry Report:https://www.maximizemarketresearch.com/inquiry-before-buying/81566
PARP Inhibitors Market Segmentation:
by Drug-type
Lynparza
Niraparib
Rucaparib
Talazoparib
Veliparib
by Indication
Ovarian Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
by Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/81566
PARP Inhibitors Market Key Players:
1. AstraZeneca
2. Tesaro
3. AbbVie Inc
4. Medivation
5. Clovis Oncology
6. Johnson & Johnson
7. GlaxoSmithKline plc
8. Pfizer Inc
9. Bristol-Myers Squibb
10.Merck KGaA
11.Genentech Inc
12.Repare Therapeutics
13.Sierra Oncology
14.Karyopharm Therapeutics Inc
15.Ono Pharmaceutical Co. Ltd
Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/global-parp-inhibitors-market/81566/
Table of content for the PARP Inhibitors Market includes:
1. Global PARP Inhibitors Market: Research Methodology
2. Global PARP Inhibitors Market: Executive Summary
• Market Overview and Definitions
• Introduction to the Global Market
• Summary
• Key Findings
• Recommendations for Investors
• Recommendations for Market Leaders
• Recommendations for New Market Entry
3.Global PARP Inhibitors Market: Competitive Analysis
• MMR Competition Matrix
• Market Structure by region
• Competitive Benchmarking of Key Players
• Consolidation in the Market
• M&A by region
• Key Developments by Companies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Market Dynamics
• PORTERS Five Forces Analysis
• PESTLE
• Regulatory Landscape by region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
• COVID-19 Impact
4 . Company Profile: Key players
• Company Overview
• Financial Overview
• Global Presence
• Capacity Portfolio
• Business Strategy
• Recent Developments
Key Offerings:
• Past Market Size and Competitive Landscape (2022 to 2029)
• Past Pricing and price curve by region (2022 to 2029)
• Market Size, Share, Size and Forecast by different segment | 2022-2029
• Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
• Market Segmentation - A detailed analysis by growth and trend
• Competitive Landscape - Profiles of selected key players by region from a strategic perspective
• Competitive landscape - Market Leaders, Market Followers, Regional player
• Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis
• Legal Aspects of business by region
• Lucrative business opportunities with SWOT analysis
• Recommendations
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 mailto:sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PARP Inhibitors Market to reach USD 11.56 Bn by 2029, emerging at a CAGR of 11.10 percent and forecast 2023-2029 here
News-ID: 3301241 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Food E-Commerce Market Valued at USD 343.31 Billion in 2024, Poised for 20.3% CA …
Food E-Commerce Market size was valued at USD 343.31 Billion in 2024 and the total Food E-Commerce revenue is expected to grow at a CAGR of 20.3% from 2025 to 2032, reaching nearly USD 1505.99 Billion.
Food E-Commerce Market Overview:
The food e-commerce market represents the digital transformation of grocery shopping, encompassing the online sale and delivery of food products, including fresh produce, pantry staples, prepared meals, and specialty items. This sector…
Defense Electronics Market Valued at USD 200 Billion in 2023, Projected to Reach …
Defense Electronics Market size was valued at USD 200 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 5.3 % from 2024 to 2030, reaching nearly USD 287.10 Bn.
Defense Electronics Market Overview:
The defense electronics market encompasses the specialized electronic systems and components integral to modern military operations. This sector includes critical technologies such as radar and sonar systems, electronic warfare (EW) capabilities, communications and…
Global Magnesium Alloys Market Poised to Grow from US$ 2.21 Billion in 2024 to U …
According to a new report by Maximizer Market Research, the Global Magnesium Alloys Market was valued at USD 2.21 billion in 2024 and is projected to reach USD 5.58 billion by 2032, growing at a CAGR of 12.25%. This growth is underpinned by rising demand from automotive & transportation, electronics, aerospace, defense, and medical industries seeking lightweight, high-performance materials.
For full access to the data, request a sample report now :https://www.maximizemarketresearch.com/request-sample/32753/
♦…
Global Bamboo Furniture Market to Grow from USD 13.75 Billion to USD 23.02 Billi …
According to a new report by Maximize Market Research, the global bamboo furniture market was valued at USD 13.75 billion in 2024 and is projected to reach USD 23.02 billion by 2032, growing at a compound annual growth rate (CAGR) of approximately 6.65%.
For full access to the data, request a sample report now :https://www.maximizemarketresearch.com/request-sample/111043/
♦ Key Highlights
♦ Market size & CAGR: USD 13.75 billion (2024) to USD 23.02 billion (2032) at…
More Releases for PARP
PARP Inhibitor Biomarkers Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitor Biomarkers Market - (By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global PARP Inhibitor Biomarkers Market is valued at US$ 879.8…
Parp Inhibitors Market Driven by Demand for Immersive Technologies Across Indust …
Global Parp Inhibitors Market Impact of AI and Automation
The PARP inhibitors market has seen remarkable growth in recent years, primarily driven by advances in cancer treatment and the increasing prevalence of cancer globally. These inhibitors, which block the enzyme poly (ADP-ribose) polymerase (PARP), are proving to be highly effective in targeting specific cancer cells, especially in cancers with DNA repair deficiencies like ovarian, breast, and prostate cancers. The approval of…
China Market Analysis of PARP Inhibitors: Growth Opportunities
Global PARP Inhibitors Market: Introduction
A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA.
Read Report Overview - https://www.transparencymarketresearch.com/parp-inhibitors-market.html
Global PARP Inhibitors Market: Competition Landscape
Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is…
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
PARP Inhibitors Market Dynamics, Segments, Size and Demand, 2017 - 2027
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
Global PARP Inhibitor Market: Size, Trends And Forecasts (2016-2020)
Scope of the Report
The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib.
The report analyses the global Lynparza market in detail along with the regional analysis as…
